![SI050021: Elbasvir-d6 label-new 4-[8-Amino-3-[1-oxo-4-[(1-oxo-2-butyn-1-yl)amino]butyl]imidazo[1](https://cdn.shopify.com/s/files/1/0810/4889/5786/files/SI050021.svg?v=1699651363)
Pay in 4 interest-free payments of $43.75 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
4-[8-Amino-3-[1-oxo-4-[(1-oxo-2-butyn-1-yl)amino]butyl]imidazo[1
enabling enzymatic extension to sialylated and fucosylated structures such as sialyl-LacNAc and Lewis antigens
Triantennary β-D-GalNAc pentaethyleneglycol (PEG5) carboxylic acid ligand
2-[2-(2-Azidoethoxy)ethoxy]ethyl 2-acetamido-2-deoxy-β-D-galactopyranoside
SI050021: Elbasvir-d6 label-new 4-[8-Amino-3-[1-oxo-4-[(1-oxo-2-butyn-1-yl)amino]butyl]imidazo[1C49H49D6N9O7 888. 05 HIV Infection Elbasvir d6 Trideuteriomethyl N [(2S) 3 methyl 1 [(2S) 2 [5 [(6S) 3 [2 [(2S) 1 [(2S) 3 methyl 2 (trideuteriomethoxycarbonylamino)butanoyl]pyrrolidin 2 yl] 1H imidazol 5 yl] 6 phenyl 6H indolo[1,2 c][1,3]benzoxazin 10 yl] 1H imidazol 2 yl]pyrrolidin 1 yl] 1 oxobutan 2 yl]carbamate
